Macquarie Group’s ANI Pharmaceuticals ANIP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-291,129
Closed -$26.7M 885
2025
Q3
$26.7M Sell
291,129
-132,588
-31% -$10.8M 0.03% 580
2025
Q2
$27.6M Sell
423,717
-25,118
-6% -$1.64M 0.03% 575
2025
Q1
$30.1M Sell
448,835
-113,768
-20% -$6.8M 0.04% 545
2024
Q4
$31.1M Buy
562,603
+70,956
+14% +$4.07M 0.04% 543
2024
Q3
$29.3M Buy
491,647
+103,570
+27% +$6.32M 0.03% 588
2024
Q2
$24.7M Buy
388,077
+174,178
+81% +$11.3M 0.03% 609
2024
Q1
$14.8M Sell
213,899
-16,163
-7% -$976K 0.02% 741
2023
Q4
$12.7M Buy
+230,062
New +$12.7M 0.01% 775
2018
Q4
Sell
-200
Closed -$11K 2244
2018
Q3
$11K Buy
+200
New +$12.2K ﹤0.01% 1980

Other funds holding ANIP